抗病毒治疗

目的探讨肝组织HBVdna在抗病毒治疗中的变化及其作用。

AIM : To study the role of intrahepatic HBV DNA in antiviral therapy .

AIDS抗病毒治疗的历史、现状与未来

Antiviral therapy for AIDS-history , present and future

中国慢性乙肝患者接受抗病毒治疗的比例较低（19%）。

In china , the rate of chronic hepatitis B accepting antivirotic treatment is very low ( 19 % ) .

河南省开封市某县AIDS患者抗病毒治疗效果评价

The Evaluation of Anti-viral Treatment in AIDS Patients in Henan Province

河南省HIV抗病毒治疗耐药性研究

The drug resistance study of HIV anti-virus treatment of Henan province

乙型肝炎e抗原阳性慢性乙型肝炎的抗病毒治疗

Antiviral treatment of HBeAg positive chronic hepatitis B

乌鲁木齐市88例HIV感染者抗病毒治疗状况调查

Investigation on antiretroviral treatment for 88 HIV-infected persons in Urumqi

艾滋病是无法治愈的，因为细胞中潜隐感染HIV病毒抵抗抗病毒治疗。

AIDS is incurable because cells latently infected with HIV resist antiviral therapy .

抗病毒治疗在HBV相关性肝癌中的应用现状与展望

Application and Prospects of Antiviral Therapy in HBV Related Hepatoma

148例AIDS患者抗病毒治疗疗效分析

Antiviral therapy for 148 cases of AIDS

目的建立HBV携带者是否需要抗病毒治疗的无创性预测指标。

Objective To establish non-invasive predictors of antiviral therapy for chronic HBV carriers .

29例进行过拉米呋啶抗病毒治疗的病例中P区552位点变异率为96.6%（28/29）。

The mutation rates of P section 552 site were 96.6 % ( 28 / 29 ) in 29 patients treated by lamivudine .

福建省HIV感染者临床进展和抗病毒治疗的效果观察

The clinical progression of individuals with HIV infection in Fujian and their effectiveness with anti-retroviral therapy

该调查报告指出，这不仅是因为有新感染的人群，还因为抗病毒治疗（ART）成功得到广泛应用。

This was because of the combined effects of new infections and a successfully expanded antiretroviral treatment [ ART ] programme , the report said .

从村卫生室医务人员AIDS机会性感染及抗病毒治疗知识知晓率来看，21个问题知晓率均在90%以下。

The awareness rate of 21 questions about AIDS opportunistic infections and anti-HIV treatment is below 90 % .

用HBVdna定量和HBeAg定量监控抗病毒治疗

Monitoring of antiviral therapy of hepatitis B with quantitative determination of HBV DNA and HBeAg

接受抗病毒治疗的HIV感染人群临床症状和死亡及其影响因素研究

The Factors Associated with Clinical Symptoms and Death of HIV Infections Treated by Highly Active Antiretroviral Therapy

抗病毒治疗对慢性HBV感染者长期临床预后的影响研究。

Influence of antiviral treatment to the long term prognosis of patients with chronic HBV infection .

高效抗病毒治疗HIV感染后出现肿胀性红斑狼疮：一种免疫恢复现象

Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection : A manifestation of immune restoration

山东地区HBV基因型分布及拉米夫定抗病毒治疗对基因分型的影响

Distribution of HBV genotypes in Shandong province and it 's relationship with the antiviral effect of lamivudine

关于HIV-1进入抑制剂的研究是HIV研究领域近年来的一个新进展，为人类深入了解HIV发病机理，开发新的抗病毒治疗药物，并最终战胜HIV带来了新的曙光。

Current research on HIV entry inhibitors is a tremendous progress in the field of HIV treatment .

接受抗病毒治疗和延迟发病年份，是延长AIDS患者生存年限的主要因素。

Receipt of anti-virus therapy and delay of outbreak year are major factors for extending the AIDS patients ' survival period .

合并HBV非小细胞肺癌化疗同时使用抗病毒治疗的临床应用

The Clinical Applications of Combined HBV Approach to Chemotherapy for Non-small Cell Lung Cancer while Adoption of Antivirus Therapy

应用Cox比例风险模型分析抗病毒治疗对慢性乙型重型肝炎预后的影响

Influence of nucleoside treatment on prognosis of patients with chronic severe hepatitis B

我们对81例HCV感染的肝移植病人进行了抗病毒治疗，评价了该方法对病情的影响。

We evaluated the effect of antiviral therapy on disease progression in81 HCV-infected liver transplantation recipients .

慢性HCV肝炎抗病毒治疗

Anti virus Therapy on Chronic HCV

为此，有必要对HCV感染者进行抗病毒治疗和适当隔离。

The serum HCV RNA positive patients should be subject to antiviral treatment and adequately isolated .

HBeAg水平与下降速率在抗病毒治疗中的意义

Role of HBeAg level and its decreasing rate in antiviral therapy

方法71例HBeAg阳性的慢性乙肝患者分别接受序贯治疗、拉米夫定和干扰素抗病毒治疗，总疗程为48周，随访24周。

METHODS : 71 patients with HBeAg-positive chronic hepatitis B were studied .

中国东北地区未经抗病毒治疗的HIV/AIDS患者HIV毒株的耐药基因变异研究

Study of genotypic resistance mutation to antiretroviral drugs of HIV strains of treatment-naive HIV / AIDS patients in the northeast of China